MetLife (MET) Q2 2026 (USD): Adj. EPS 2.43 (exp. 2.29), revenue 19.154bln (exp. 19.709bln). To buyback USD 2bln of shares.

MetLife (MET) Q2 2026 (USD): Adj. EPS 2.43 (exp. 2.29), revenue 19.154bln (exp. 19.709bln). To buyback USD 2bln of shares.

The split print, earnings beat against a revenue miss, is a familiar pattern for large life insurers, where the bottom line is often driven by investment income, reserve releases, and expense discipline rather than top-line premium growth, so the EPS number alone has historically told less than the composition beneath it. For this peer set, variable investment income and the performance of the alternatives book are the usual swing factors quarter to quarter, and the quality of the beat matters more than its size. The announced buyback is the cleaner signal: capital return of this kind from a big life insurer typically reflects confidence in excess capital generation and tends to be received as the durable takeaway, since insurers in this position have historically used repurchases as the primary lever for deploying surplus once solvency buffers are comfortably met. The revenue shortfall against consensus is worth weighing against premium flow trends and any FX drag from the international operations, which for this group spans Japan and other markets where currency translation has periodically flattered or masked underlying growth. Follow-ons that have mattered in comparable prints are the segment detail on the conference call, net investment spread commentary, and any guidance on the pace of future capital return.